Back to Chevy Chase Trust Holdings, LLC Chevy Chase Trust Holdings, LLC

REGNREGN
31 quarters

Position history for Chevy Chase Trust Holdings, LLCChevy Chase Trust Holdings, LLC's holdings in Regeneron Pharmaceuticals, Inc.

Yes. Chevy Chase Trust Holdings holds 179,056 shares of REGN (Regeneron Pharmaceuticals), worth $111.6M, as of its Q2 2026 13F filing. It reduced the position by 26,777 shares (-13.0%) from Q1 2026. Chevy Chase Trust Holdings has held REGN in every 13F on record since Q4 2018, 31 quarterly filings. REGN is 0.3% of Chevy Chase Trust Holdings' reported 13F portfolio.

Current Value

$111.6M

Current Shares

179,056

Total Value Change

+$66.9M

Total Shares Change

+59,358

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
179,056
-13.0%
$111.6M0.3%$622.81
0
2026-Q1
Increased
205,833
+2.5%
$159M0.5%$770.59
37
2025-Q4
Decreased
200,747
-1.2%
$155M0.4%$768.90
0
2025-Q3
Decreased
203,152
-1.7%
$114.2M0.3%$559.40
0
2025-Q2
Decreased
206,728
-6.5%
$108.5M0.3%$521.53
0
2025-Q1
Decreased
221,210
-3.7%
$140.3M0.4%$629.11
0
2024-Q4
Decreased
229,767
-3.6%
$163.7M0.5%$705.67
0
2024-Q3
Decreased
238,379
-1.4%
$250.6M0.8%$1,041.41
0
2024-Q2
Decreased
241,754
-0.3%
$254.1M0.8%$1,041.20
0
2024-Q1
Decreased
242,380
-2.9%
$233.3M0.8%$953.49
0
2023-Q4
Decreased
249,577
-0.5%
$219.2M0.8%$870.08
0
2023-Q3
Decreased
250,921
-0.7%
$206.5M0.8%$815.27
0
2023-Q2
Decreased
252,732
-0.7%
$181.6M0.7%$711.82
0
2023-Q1
Decreased
254,468
-1.4%
$209.1M0.8%$813.99
0
2022-Q4
Decreased
258,134
-7.9%
$186.2M0.8%$714.75
0
2022-Q3
Increased
280,344
+5.6%
$193.1M0.8%$682.43
46
2022-Q2
Increased
265,463
+6.2%
$156.9M0.6%$585.60
45
2022-Q1
Increased
250,035
+7.8%
$174.6M0.6%$691.89
46
2021-Q4
Increased
231,874
+4.8%
$146.4M0.5%$625.62
38
2021-Q3
Increased
221,256
+22.2%
$133.9M0.5%$599.52
44
2021-Q2
Increased
180,995
+6.9%
$101.1M0.3%$553.32
38
2021-Q1
Increased
169,337
+23.5%
$80.1M0.3%$468.72
43
2020-Q4
Decreased
137,130
-3.5%
$66.3M0.2%$478.59
0
2020-Q3
Increased
142,045
+6.5%
$79.5M0.3%$554.55
38
2020-Q2
Increased
133,381
+56.2%
$83.2M0.3%$617.82
50
2020-Q1
Increased
85,403
+1.3%
$41.7M0.2%$483.73
35
2019-Q4
Decreased
84,293
-3.6%
$31.7M0.1%$371.97
0
2019-Q3
Decreased
87,435
-29.8%
$24.3M0.1%$274.81
0
2019-Q2
Decreased
124,622
-16.2%
$39M0.2%$310.07
0
2019-Q1
Increased
148,728
+24.3%
$51.6M0.2%$406.78
43
2018-Q4
First report
119,698
-
$44.7M0.2%$370.01
0

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used